Stay updated with breaking news from Research Development Rd Day. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bicycle Therapeutics (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, is today hosting a Research & Development (R&D) Day for investors and analysts in New York to provide clinical updates for BT8009, BT748
Nectin-4 portfolio comprised of BT8009 and BT7480 represents potential opportunity to become leader in treating Nectin-4-driven cancers, starting with metastatic urothelial cancer Updated BT8009...
NEW YORK, Sept. 26, 2023 -- Ovid Therapeutics Inc. , a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related disorders,...
- New Clinical Data on ARO-RAGE Show Continued Dose Response with Single Inhaled Dose of 184 mg Achieving Mean Knockdown of 90% and Max of 95% - Adipose Delivery Platform Achieved Single Dose... | June 1, 2023
Bristol Myers Squibb today announced that the company will hold a Research & Development Day in New York City on Thursday, September 14, 2023, at 9:00 a.m. Company executives will provide... | May 31, 2023